> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA, FTC Warn 7 Companies About Covid Claims
- URL: https://www.fdaweb.com/fda-ftc-warn-7-companies-about-covid-claims/
- Published: 2022-03-30T12:00:00.000Z
- Updated: 2026-09-14T17:38:49.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5151481

FDA and the Federal Trade Commission (FTC) have sent Warning Letters to seven companies for selling CBD (cannabidiol) products using research studies to claim or imply misleadingly that the products will cure, mitigate, treat, or prevent Covid-19\. FDA says it has not approved or authorized any drug containing CBD to treat or prevent Covid-19.

The Warning Letters say each company’s products are unapproved new drugs that also are misbranded. The letters cite some of the claims made for the products and direct the companies to take immediate action to address the violations cited. They were told to respond by e-mail within 48 hours describing the specific steps they have taken to address the violations and prevent their recurrence, with related documentation.

Also included is an FTC cease-and-desist demand.

The letters were sent to [Curgenics](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cureganics-627288-03282022?utm%5Fmedium=email&utm%5Fsource=govdelivery), [Heaven’s Organics](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/heavens-organic-llc-627359-03282022?utm%5Fmedium=email&utm%5Fsource=govdelivery), [Functional Remedies](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/functional-remedies-llc-dba-synchronicity-hemp-oil-627208-03282022?utm%5Fmedium=email&utm%5Fsource=govdelivery), [Greenway Herbal Products](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/greenway-herbal-products-llc-627042-03282022?utm%5Fmedium=email&utm%5Fsource=govdelivery), [CBD Social](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cbd-social-627044-03282022?utm%5Fmedium=email&utm%5Fsource=govdelivery), [UPSY](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/upsy-llc-627962-03282022?utm%5Fmedium=email&utm%5Fsource=govdelivery), and [Nature’s Highway](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/natures-highway-627304-03282022?ref=fdaweb.com).